Left atrial phasic transport function closely correlates with fibrotic and arrhythmogenic atrial tissue degeneration in atrial fibrillation patients: cardiac magnetic resonance feature tracking and voltage mapping.

Low-voltage area Atrial fibrillation Cardiac magnetic resonance imaging Catheter ablation Left atrial function

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
08 09 2021
Historique:
received: 27 12 2020
accepted: 22 02 2021
pubmed: 12 3 2021
medline: 21 10 2021
entrez: 11 3 2021
Statut: ppublish

Résumé

To characterize the association of phasic left atrial (LA) transport function and LA fibrosis guided by multimodality imaging containing cardiac magnetic resonance imaging (CMR) feature tracking and bipolar voltage mapping. Consecutive patients presenting for first-time ablation of atrial fibrillation (AF) were prospectively enrolled. Each patient underwent CMR prior to the ablation procedure. LA phasic indexed volumes (LA-Vi) and emptying fractions (LA-EF) were calculated and CMR feature tracking guided LA wall motion analysis was performed. LA bipolar voltage mapping was carried out in sinus rhythm to find areas of low voltage as a surrogate for fibrosis and arrhythmogenesis. One hundred and sixty-eight patients were enrolled. Low-voltage areas (LVAs) were present in 70 patients (42%). Contrary to LA volume, CMR based LA-EF [odds ratio (OR) 0.88, 95% confidence interval (CI) 0.80-0.96, P = 0.005] and LA booster pump strain rate (SR) (OR 0.98, 95% CI 0.97-0.99, P = 0.001) significantly predicted presence and extent of LVA in multivariate logistic regression analysis for patients scanned in SR. In receiver operating characteristic analysis, LA-EF <40% carried a sensitivity of 83% and specificity of 76% (area under the curve 0.8; 95% CI 0.71-0.89) to predict presence of LVA. For patients scanned in AF only minimal LA-Vi on CMR (OR: 1.06; 95% CI: 1.02-1.10; P = 0.002) predicted presence of LVA. For patients scanned in SR LA-EF and LA booster pump SR are closely linked to the presence and extent of LA LVA.

Identifiants

pubmed: 33693595
pii: 6163118
doi: 10.1093/europace/euab052
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1400-1408

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Auteurs

Robert Schönbauer (R)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Jakub Tomala (J)

Department of Cardiac Electrophysiology, Heart Centre Dresden, Fetscherstraße 76, 01307 Dresden, Germany.

Bettina Kirstein (B)

Department of Cardiac Electrophysiology, Heart Centre Dresden, Fetscherstraße 76, 01307 Dresden, Germany.

Yan Huo (Y)

Department of Cardiac Electrophysiology, Heart Centre Dresden, Fetscherstraße 76, 01307 Dresden, Germany.

Thomas Gaspar (T)

Department of Cardiac Electrophysiology, Heart Centre Dresden, Fetscherstraße 76, 01307 Dresden, Germany.

Utz Richter (U)

Department of Cardiac Electrophysiology, Heart Centre Dresden, Fetscherstraße 76, 01307 Dresden, Germany.

Judith Piorkowski (J)

Department of Cardiac Electrophysiology, Heart Centre Dresden, Fetscherstraße 76, 01307 Dresden, Germany.
Steinbeis Research Institute-Rhythm and Heart, Dresden, Germany.

Marie-Sophie Schönbauer (MS)

Department of Cardiology, Krankenhaus Nord, Vienna, Austria.

Lukas Fiedler (L)

Department of Cardiology, Landesklinikum Wiener Neustadt, Wiener Neustadt, Austria.

Franz Xaver Roithinger (FX)

Department of Cardiology, Landesklinikum Wiener Neustadt, Wiener Neustadt, Austria.

Christian Hengstenberg (C)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Julia Mascherbauer (J)

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Stefan Ulbrich (S)

Department of Cardiac Electrophysiology, Heart Centre Dresden, Fetscherstraße 76, 01307 Dresden, Germany.

Christopher Piorkowski (C)

Department of Cardiac Electrophysiology, Heart Centre Dresden, Fetscherstraße 76, 01307 Dresden, Germany.
Abbott EP&HF Division, Minneapolis, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH